Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-020450
Filing Date
2020-09-29
Accepted
2020-09-29 18:26:32
Documents
1
Period of Report
2020-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 5588
  Complete submission text file 0001437749-20-020450.txt   7241
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1256 BRIARCLIFF ROAD N.E. EMTECH BIO SUITE 500 ATLANTA GA 30306
Business Address
Kollintzas Dean G (Reporting) CIK: 0001378351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39563 | Film No.: 201210062